Last $0.0078 USD
Change Today -0.0002 / -2.50%
Volume 450.5K
VMCI On Other Exchanges
Symbol
Exchange
OTC US
As of 12:13 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

vemics inc (VMCI) Snapshot

Open
$0.0072
Previous Close
$0.0080
Day High
$0.0078
Day Low
$0.0072
52 Week High
03/7/14 - $0.03
52 Week Low
04/29/14 - $0.0040
Market Cap
185.0K
Average Volume 10 Days
442.4K
EPS TTM
--
Shares Outstanding
23.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VEMICS INC (VMCI)

Related News

No related news articles were found.

vemics inc (VMCI) Related Businessweek News

No Related Businessweek News Found

vemics inc (VMCI) Details

iMedicor, Inc. builds portal-based virtual communication network for healthcare and related professionals. Its solutions allow physicians to use the Internet to exchange and share patient medical information between members of the healthcare community. The company’s portal offers hospital systems, State Health Information Exchanges, Independent Practice Associations, and Regional Health Information Organizations with communications functionalities. Its products and services include the iMedicor Social Health Information Exchange that allows physicians and other healthcare providers to exchange patient specific healthcare information through the Internet; consulting services to a community of medical and dental practices; and iMedicor ClearLobby, a Web-based portal that provides for direct communications between pharmaceutical companies and physicians for the dissemination of information on new drugs and products/devices. The company, formerly known as Vemics, Inc., was founded in 2001 and is based in Windermere, Florida.

1 Employees
Last Reported Date: 02/24/14
Founded in 2001

vemics inc (VMCI) Top Compensated Officers

Founder and Consultant
Total Annual Compensation: $114.5K
Compensation as of Fiscal Year 2013.

vemics inc (VMCI) Key Developments

iMedicor, Inc. Announces Earnings Results for the Second Quarter of 2014

iMedicor, Inc. announced earnings results for the second quarter of 2014. For the quarter, the company's revenue increased 2,026% to $382,113 compared to $18,852 in the second quarter of 2013. Net loss was $542,687 versus a net loss of $763,352 in the prior year period. The reduction in net loss was a function of increased revenue with limited increases in variable costs and also gains related to reductions in expenses and liabilities accrued in prior periods.

iMedicor, Inc. Announces the Launch of Second Cloud-Based Software Product, iCoreDental

iMedicor, Inc. announced the launch of its second cloud-based software product one week following the launch of iCoreMD. iCoreDental is a fully customizable, cloud-based, Electronic Heath Record (EHR) system for dentists. iMedicor has developed a customizable, cloud-based dental EHR software system that provides dentists with powerful tools at their fingertips to make dental care delivery more efficient and less costly. The iCoreDental platform reduces errors and ultimately, will improve patient outcomes. iCoreDental is a platform EHR that is customizable-on-demand, for specific functionality within a practice's HER software. iCoreDental includes a sophisticated practice management system, e-prescription functionality, integrated laboratory information system, electronic claims processing, comprehensive medical billing, patient scheduling with notifications. The company believes that they have built a comprehensive product with substantial marketplace demand. All sensitive patient information is transmitted securely in a HIPAA-compliant manner via the iCoreExchange, iMedicor's flagship, secure email transport network that uses NHIN DIRECT protocol, allowing providers to apply for Meaningful Use Federal Incentive funds, currently available to qualified dentists.

iMedicor Launches Proprietary iCoreMD, Cloud-Based, Customizable Electronic Health Records Platform

iMedicor Inc. has developed a customizable cloud based medical EHR software system that will provide Doctors with powerful tools at their fingertips to make management of healthcare delivery more efficient and less costly with reduced errors and ultimately, generate better patient outcomes. iCoreMD is a Medical EHR that is customizable-on-demand, for a practice group's requests for specific functionality within the practice's EHR software. iCoreMD includes a sophisticated practice management system, e-prescription functionality, integrated laboratory information system, electronic claims processing, comprehensive medical billing, patient scheduling with notifications, rules-based clinical decision making algorithms and more. All sensitive patient information is transmitted securely in a HIPAA-compliant manner via iCoreExchange, iMedicor's secure email transport network that uses NHIN DIRECT protocol, allowing providers to apply for Meaningful Use Federal Incentive funds, currently available to qualified doctors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VMCI:US $0.01 USD -0.0002

VMCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allscripts Healthcare Solutions Inc $14.90 USD +0.125
athenahealth Inc $145.23 USD +0.79
Cerner Corp $57.99 USD +0.325
Google Inc $588.35 USD +5.99
Sage Group PLC/The 399.00 GBp +2.90
View Industry Companies
 

Industry Analysis

VMCI

Industry Average

Valuation VMCI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VEMICS INC, please visit www.imedicor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.